Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.
about
Human papillomavirus and survival of patients with oropharyngeal cancer.HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.Genome stability pathways in head and neck cancersTumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancerTelomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published dataHuman papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review).A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.Counseling the patient with potentially HPV-related newly diagnosed head and neck cancerEpidemiology and survival of HPV-related tonsillar carcinomaHuman papillomavirus-associated oropharyngeal cancer: a new clinical entity.HPV-associated head and neck cancer: a virus-related cancer epidemic.Impact of HPV in Oropharyngeal Cancer.Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancerSecond primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancerImmune suppression in head and neck cancers: a reviewHLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcomeCorrelation of LMP10 expression and clinical outcome in Human Papillomavirus (HPV) positive and HPV-Negative tonsillar and base of tongue cancerHuman papillomavirus and tonsillar and base of tongue cancerThe clinical impact of HPV tumor status upon head and neck squamous cell carcinomas.Discrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry.Oropharyngeal cancer epidemic and human papillomavirus.Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma.A different entity: a population based study of characteristics and recurrence patterns in oropharyngeal squamous cell carcinomas.Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.Incidence of tonsillar cancer in northern Sweden: Impact of human papilloma virusPrevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer.Is human papillomavirus involved in laryngeal neuroendocrine carcinoma?Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinomaNew insights into human papillomavirus-associated head and neck squamous cell carcinoma.Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma.Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcomeAbsent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.Histological subtypes and characteristic structures of HPV-associated oropharyngeal carcinoma: study with Japanese cases.Role of human papillomavirus in the pathogenesis of oral squamous cell carcinoma.Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina.In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study.
P2860
Q27851567-B93BBF8C-3DB3-404B-9FCE-DD9BF70FF17EQ27852254-9C095FC7-F8C9-42C7-A927-E02AA7E7562FQ28391355-6033D274-28A1-47D5-8A40-071F74B28678Q28728574-001CAF98-1496-4F8A-A46A-AA6188268CD7Q30248577-182DC004-2E4D-4AA4-9549-1B72FF93D6E0Q31136389-C2BED4A5-FEF9-4097-9D62-C7F79FD6367BQ33778119-3311C5DD-690D-48FE-8C80-C2844BB253A0Q33836496-47AC7260-4CAD-483E-8497-E38A89F212C6Q33908473-73940B55-59E4-46EE-8239-6800E2057083Q33913591-946B1EE3-E46A-4BA0-B9B5-3E4E412F9ADCQ34088512-17390EE3-6487-4D0C-9C5D-2DF6B0DDB588Q34114152-0F022F5B-922E-4D1C-BBFF-79FA57422982Q34479115-E889E4E2-0731-4FDB-881A-5A7C24BF1E5CQ34596781-355EB638-60B4-4FE0-9B31-F7CFBC89FAF3Q34667840-EEF68D5C-A58F-4478-8B95-DECA6AD98A8EQ34700675-A2D878B1-3C6D-4CFC-A440-D2F183DD08BEQ35018702-146A3413-2095-46FF-85B8-996C949C2ADDQ35154161-98ADF15C-B636-49C1-9185-2FA2FCCD0BE1Q35232819-BCDB09FD-1FB1-43D1-BF71-C2250B57E563Q35344832-5B3D3611-C920-4A18-A393-418CD9583136Q35533875-7FBF5693-447E-4D49-8C68-F0E60B10E9A1Q35804927-FC8CFBB5-637F-465D-97A8-FCD15AF05F77Q35825299-01F5A64D-4459-4EBD-A6AC-7F786545CA59Q36000879-F9E9FC63-8439-4A99-A67E-505DD021A640Q36050759-D7E9F089-60D1-4B2D-B0EF-B34F505CA360Q36067876-8A2478EE-5FB7-4D58-93D1-A06B6EB8F0CAQ36237523-385361DE-3943-4975-AD7B-15FDAF6C9A13Q36336570-C72D921F-AF8F-4731-8716-A2D5CB38184AQ36530626-80FB210E-CBAE-4473-9CB1-A18F123BF768Q36578125-9AAABBA3-7899-437E-968A-FA8C66587B8AQ36747392-3BACDFD8-4A76-4C9F-9751-EE3F486DD30CQ36880375-E152945E-3983-45E9-B63E-1FC22E864ABAQ37003406-52E0E187-AD30-4065-A4FE-061D998A7345Q37170012-F90BB94D-A4FB-4DA8-BC0B-147C26A1D5C6Q37236260-D0BBD384-CD54-4629-BAAE-11D172EBC869Q37416145-51CF0192-B10C-4E14-A089-629EC19C7B31Q37425877-F6C1E339-E58B-47A7-A7E2-3A28E07AB8CFQ37527733-98C0CCDC-3AEF-497E-ADA9-0E3C893C4CF1Q37650660-86B5A3BD-F1E8-4B09-8AF9-278C292AACA2Q37684670-10D9D247-D7DF-4024-89AA-059145EB0385
P2860
Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Human papillomavirus is a favo ...... y the expression of E6 and E7.
@en
type
label
Human papillomavirus is a favo ...... y the expression of E6 and E7.
@en
prefLabel
Human papillomavirus is a favo ...... y the expression of E6 and E7.
@en
P2093
P2860
P50
P1433
P1476
Human papillomavirus is a favo ...... by the expression of E6 and E7
@en
P2093
Eva Munck-Wikland
Hanna Dahlstrand
Johan Lindholm
Liselotte Onelöv
Mircea Romanitan
Tina Dalianis
Torbjörn Ramqvist
P2860
P304
P356
10.1016/J.MOLONC.2007.08.005
P577
2007-09-01T00:00:00Z